Funding

The Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient organisations for allergy in Australia, have developed the first National Allergy Strategy for Australia, in collaboration with other stakeholder organisations. ASCIA and A&AA greatly appreciate the funding support that has enabled the development and implementation of the National Allergy Strategy.

Development of the National Allergy Strategy

While funding from the Australian Government Department of Health has supported implementation since 2015, development of the National Allergy Strategy, including two Allergy Summits was funded by unrestricted education grants obtained by ASCIA. These grants were from the following organisations:

Major supporters:

  • Mylan (formerly Alphapharm)
  • Seqirus (formerly bioCSL)
  • Stallergenes Greer
  • Bayer

Other supporters:

  • Nutricia
  • Nestlé Nutrition
  • Merck Sharp & Dohme

It is important to note that the content of both the Allergy Summits and the National Allergy Strategy was been independently developed and has not been influenced by organisations that have provided unrestricted educational grants.

Implementation of the National Allergy Strategy

Government funding

  • Australian Government Department of Health
  • Australian Digital Health Agency

Unrestricted education grants
The following organisations provided unrestricted education grants to help implement the National Allergy Strategy projects:

Major supporters:

  • PCH Foundation
  • GSK
  • Mylan
  • Abbott
  • Nutricia
  • Bayer

Other supporters:

  • DBV Technologies
  • Stallergenes Greer
  • Abacus dx
  • Nestle Nutrition

It is important to note that the implementation of the National Allergy Strategy has not been influenced by organisations that have provided unrestricted educational grants.

Private donations

  • The National Allergy Strategy has received private donations from families and ASCIA members to help implement the National Allergy Strategy

Content updated August 2019

National Allergy Strategy Rationale

Allergic diseases have become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades, contributing to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic diseases and their carers.

Information Partner

healthdirect: trusted health information
Funded by the governments of Australia

National Allergy Strategy Websites and Courses

All about Allergens
All about Allergens
The next step for cooks and chefs
The next step for cooks and chefs
Authorised Officers Resources
All about Allergens
Food allergy prevention
e-training for health professionals
Food allergy prevention e-training for health professionals
Paediatric atopic dermatitis
e-training for health professionals
Paediatric atopic dermatitis e-training for health professionals
Food Allergy Education
for the community
Food Allergy Education
Food Allergy Aware - Hub
Food Allergy Aware - Hub
250K for teens and young adults
250K
Nip Allergies in the Bub

Lead organisations

ascia logo 2018s
Australasian Society of Clinical Immunology and Allergy (ASCIA) is the leading medical organisation for allergy in Australia. 

aaa logo 2018s
Allergy & Anaphylaxis Australia (A&AA) is the leading patient support organisation for allergy in Australia. 

The National Allergy Strategy has received funding from the Australian Government Department of Health for the following projects:
Food allergy prevention | 250K Youth Project | Food service | Drug allergy | Shared Care Model

© National Allergy Strategy Aug 2015 | Contact Us | Disclaimer | Privacy | Sitemap